Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BETTER: Bivalirudin in Late PCI for STEMI
NCT04185077Phase 4Unknown
- Sponsor
- The Second Xiangya Hospital
- Start
- Nov 2019
- Primary completion
- Dec 2020
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 4 trial of bivalirudin in ST elevation myocardial infarction (STEMI), sponsored by The Second Xiangya Hospital. Status: unknown.
02
Drugs
bivalirudin
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT04185077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04185077.